Early estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE): use of a unique community and laboratory national data-linked cohort study.
暂无分享,去创建一个
Colin Simpson | A. Sheikh | C. Robertson | L. Ritchie | N. Lone | J. McMenamin | R. Gunson | A. Sheikh
[1] Colin Simpson,et al. Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[2] L. Smeeth,et al. Text messaging reminders for influenza vaccine in primary care: protocol for a cluster randomised controlled trial (TXT4FLUJAB) , 2014, BMJ Open.
[3] Colin Simpson,et al. Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study. , 2012, The Lancet. Infectious diseases.
[4] T. Stukel,et al. Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method. , 2012, Archives of internal medicine.
[5] P. Simmonds,et al. Sero-Prevalence and Incidence of A/H1N1 2009 Influenza Infection in Scotland in Winter 2009–2010 , 2011, PloS one.
[6] D. Skowronski,et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009 , 2011, BMJ : British Medical Journal.
[7] W Carman,et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[8] M. Valenciano,et al. Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study , 2011, PLoS medicine.
[9] Colin Simpson,et al. Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. , 2010, Health technology assessment.
[10] Libo Dong,et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.
[11] Colin Simpson,et al. The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004 , 2008, BMC infectious diseases.
[12] J. Hippisley-Cox,et al. Inequalities in uptake of influenza vaccine by deprivation and risk group: time trends analysis. , 2007, Vaccine.
[13] D. Skowronski,et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. , 2007, Vaccine.
[14] J. Nelson,et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. , 2006, International journal of epidemiology.
[15] E. D. Kilbourne. Influenza Pandemics of the 20th Century , 2006, Emerging infectious diseases.
[16] Michael W. Taylor,et al. Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology. , 2005, British journal of clinical pharmacology.
[17] Keiji Fukuda,et al. Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.
[18] R G Newcombe,et al. Confidence limits for the ratio of two rates based on likelihood scores: non-iterative method. , 2003, Statistics in medicine.
[19] K Harley,et al. Quality of Scottish Morbidity Record (SMR) data. , 1996, Health bulletin.
[20] R M Milne,et al. Completeness and accuracy of morbidity and repeat prescribing records held on general practice computers in Scotland. , 1996, The British journal of general practice : the journal of the Royal College of General Practitioners.